An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US

TerminatedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

May 20, 2022

Study Completion Date

May 20, 2022

Conditions
Alzheimers Disease
Trial Locations (22)

11772

South Shore Neurologic Associates, P.A., Patchogue

19001

Abington Neurological Associates, Abington

27204

Carolina Clinical Research & Consulting, LLC, Asheboro

28105

Research Site, Matthews

29935

Coastal Neurology, PA, Port Royal

32960

Vero Beach Neurology and Research Institute, Vero Beach

33012

New Life Medical Research Center, Inc, Hialeah

33157

Imic, Inc., Palmetto Bay

33180

Miami Jewish Health System, Inc, Miami

33487

Research Site, Boca Raton

33952

Neurostudies, Inc, Port Charlotte

34205

Research Site, Bradenton

37909

Genesis Neuroscience Clinic, Knoxville

44718

Research Site, Canton

45459

Dayton Center for Neurological Associates, Centerville

60631

Northwest Neurology, Chicago

65721

Research Site, Ozark

89128

Las Vegas Medical Research, Las Vegas

91355

Mehdi Meratee MD, Valencia

91910

Research Site, Chula Vista

97225

Center for Cognitive Health, Portland

05201

The Memory Clinic, Bennington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY